Physician

Carl Louis Schopfer, D.O.

According to 2025 Medicare claims, Carl Schopfer, D.O. (NPI: 1285677492) practices general practice in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08080-4006.

Schopfer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 198 traditional Medicare patients, billed 394 HCPCS/CPT codes, and received $19,345 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,844 prescription claims across 284 beneficiaries totaling $148,406 in drug costs, led by Januvia (Sitagliptin Phosphate). DME data shows 12 claims. Open Payments data shows 15 records totaling $342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,849 to $376.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	107	425	$30,832
2016	94	459	$28,216
2017	76	332	$19,911
2018	64	320	$18,748
2019	59	307	$18,870
2020	41	154	$9,996
2021	45	178	$12,091
2022	43	149	$11,385
2023	193	343	$20,591
2024	198	394	$19,345

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	3,255	$191,835
2016	115	2,882	$168,069
2017	91	2,108	$140,219
2018	84	1,741	$134,560
2019	77	1,534	$113,980
2020	78	1,515	$111,578
2021	78	1,327	$83,667
2022	78	1,240	$100,036
2023	257	1,681	$170,218
2024	284	1,844	$148,406

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	33	129	$1,388
2016	36	127	$4,028
2017	17	65	$724
2018	30	88	$1,082
2019	13	56	$316
2020	12	59	$372
2021	N/R	45	$316
2022	11	49	$294
2023	83	186	$1,054,942
2024	N/R	12	$212

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	176	281	$56
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	27	28	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	26	31	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	14	14	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Januvia	Sitagliptin Phosphate	20	1,800	$31,485
Ozempic	Semaglutide	25	762	$23,250
Eliquis	Apixaban	13	1,050	$18,892
Albuterol Sulfate Hfa	Albuterol Sulfate	58	1,674	$2,435
Esomeprazole Magnesium	Esomeprazole Magnesium	23	1,880	$1,211

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	12	$212

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$342	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carl Louis Schopfer, D.O.?

Tedicare shows public-source Medicare data for Carl Louis Schopfer, D.O. (NPI 1285677492), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl Louis Schopfer, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carl Louis Schopfer, D.O.?

Carl Louis Schopfer, D.O. is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Carl Louis Schopfer, D.O. have Open Payments data?

Carl Louis Schopfer, D.O. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.